Matthew Herper covers medical innovation — both its promise and its perils. SAN FRANCISCO — At the end of a roundtable lunch with a group of reporters, Pfizer CEO Albert Bourla became impassioned. He ...
In a move that might allow them to sell drugs directly to patients, some drugmakers are getting into the telehealth business. Some major pharmaceutical companies are getting into the telehealth ...
For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions. The company has reaped nearly $100 billion from selling COVID ...
I reaffirm my Buy rating on Pfizer due to expected promising updates on danuglipron and strong capital efficiency metrics, despite the recent stock pullback. Pfizer's management is expected to ...
PostEra's machine learning technology is intended to accelerate the drug discovery process by designing novel molecular structures with optimised potency and drug-like properties. PostEra's approaches ...
Pfizer is one of the world's largest and oldest drug companies. Thanks to its Covid vaccine, shares rose dramatically during the pandemic. Now that the stock has sharply corrected, long-term investors ...
Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on track, which should significantly boost the drugmaker's bottom line. Pfizer's ...
Pfizer is strengthening its franchise in respiratory vaccines and treatments, Dr. Mikael Dolsten, the chief scientific officer, said on the Nov. 1 call. It’s racing against GSK and Moderna to be first ...
SAN FRANCISCO, Dec. 7, 2020 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today announced a strategic partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback